Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy.
Weidhaas J, Marco N, Scheffler AW, Kalbasi A, Wilenius K, Rietdorf E, Gill J, Heilig M, Desler C, Chin RK, Kaprealian T, McCloskey S, Raldow A, Raja NP, Kesari S, Carrillo J, Drakaki A, Scholz M, Telesca D.
Weidhaas J, et al. Among authors: desler c.
J Immunother Cancer. 2022 Feb;10(2):e003625. doi: 10.1136/jitc-2021-003625.
J Immunother Cancer. 2022.
PMID: 35115362
Free PMC article.